90.7 F
San Fernando
Friday, Jun 2, 2023

Amgen Inks Deal to Make Cardiac Drugs

The Thousand Oaks drug maker Amgen Inc. has agreed to develop heart failure drugs with the San Francisco company Cytokinetics Inc. The drug activates a form of protein that helps heart muscles contract to pump blood. Cytokinetics will get a $42 million up-front fee. Amgen has bought almost 3.5 million shares of company stick.

Featured Articles

Related Articles